HNB
MIRM icon

Huntington National Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Huntington National Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1K Sell
172
-15
-8% -$1.51K ﹤0.01% 1772
2026
Q1 		$17.3K Sell
187
-2
-1% -$188 ﹤0.01% 1695
2025
Q4 		$14.9K Buy
189
+138
+271% +$9.9K ﹤0.01% 1686
2025
Q3 		$3.74K Hold
51
– – ﹤0.01% 2081
2025
Q2 		$2.6K Buy
+51
New +$2.27K ﹤0.01% 2150

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Huntington National Bank's MIRM Position: Q2 2026 in Review

Huntington National Bank reduced its Mirum Pharmaceuticals (MIRM) stake by 8% in Q2 2026, selling an estimated $1.51K and leaving 172 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.

Huntington National Bank first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Huntington National Bank held 172 shares of Mirum Pharmaceuticals worth $20.1K as of Q2 2026.
  • Huntington National Bank sold 15 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.51K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1772 holding.
  • Huntington National Bank first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.